Vaccine conjugate

Inventors

Craig E. WhitfillFollow
Tommy L. FredericksenFollow
Julius K. TyczkowskiFollow
James P. Thaxton Jr.Follow
John A. Thoma, University of Arkansas, FayettevilleFollow

Document Type

Patent

Publication Date

4-25-2001

Abstract

Describes a method of producing active immunity against a viral disease in an animal subject. It comprises of administering a vaccine conjugate consisting essentially of a live virus and a neutralizing factor bound to the live virus to the subject. The neutralizing factor is selected from the group consisting of antibodies and antibody fragments. The live virus is one capable of producing disease in the subject, and the antibody or antibody fragment is one capable of neutralizing the live virus.

Department

Chemistry & Biochemistry

Patent Number

EP0755684 (B1); DE69033728 (T2); DK0755684 (T3); ES2158200 (T3)

Application Number

EP0755684 (A1)

Application Filed

10-1-1990

Assignee

University of Arkansas (Fayetteville, AR)

Comments

John A. Thoma, Department of Chemistry and Biochemistry

Citation

Whitfill, C. E., Fredericksen, T. L., Tyczkowski, J. K., Thaxton, J. P., & Thoma, J. A. (2001). Vaccine conjugate. Patents Granted. Retrieved from https://scholarworks.uark.edu/pat/173